Rational prescribing in primary care (RaPP): Economic evaluation of an intervention to improve professional practice

PLoS Medicine

Volumn 3, Issue 6, 2006, Pages 0792-0799

  Fretheim, Atle ^a   Aaserud, Morten ^a   Oxman, Andrew D ^a  

^a Norwegian Knowledge Centre for Health Services   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT; ANTIHYPERTENSIVE AGENT; HYPOCHOLESTEROLEMIC AGENT;

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DRUG COST; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; HYPERTENSION; MEDICAL PRACTICE; NORWAY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DRUG UTILIZATION; ECONOMICS; GENERAL PRACTICE; HEALTH PROMOTION; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARD; STATISTICAL MODEL;

ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; COST SAVINGS; COST-BENEFIT ANALYSIS; DRUG COSTS; DRUG UTILIZATION; FAMILY PRACTICE; GUIDELINE ADHERENCE; HEALTH PROMOTION; HUMANS; MODELS, ECONOMETRIC; NORWAY; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 33745584068     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030216     Document Type: Article

References (14)

1. Grimshaw JM, Shirran L, Thomas R, Mowatt G, Fraser C, et al. (2001) Changing provider behavior: An overview of systematic reviews of interventions. Med Care 39: II2-II45.
2. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, et al. (2004) Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 8: 1-72.
3. Fretheim A, Oxman AD, Håvelsrud K, Treweek S, Kristoffersen DT, et al. (2006) Rational Prescribing in Primary Care (RaPP): A cluster randomized trial of a tailored intervention. PLoS Med 3: e134. DOI: 10.1371/journal.pmed. 0030134
4. Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration (2003) Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials. Lancet 362: 1527-1535.
5. Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, et al. (2003) Health outcomes associated with various antihypertensive therapies used as first-line agents: A network meta-analysis. JAMA 289: 2534-2544.
6. Fretheim A, Aaserud M, Oxman A (2005) Economic analyses of an intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs [study protocol]. Oslo: Norwegian Knowledge Centre for Health Services. Available: http://www.kunnskapssenteret.no/filer/Protocol_AF_0505.pdf. Accessed 24 May 2005.
7. Norges Bank (2005) Exchange rates-Annual. Oslo: Norges Bank. Available: http://www.norgesbank.no/english/statistics/exchange/kurs_ae1.html. Accessed 9 May 2005.
8. Fretheim A, Oxman AD (2005) Restrictions put on reimbursement of antihypertensive drugs other than thiazides: Interrupted time series [study protocol]. Oslo: Norwegian Knowledge Centre for Health Services. Available: http://www.kunnskapssenteret.no/filer/ProtokollTiazid050627.pdf. Accessed 2 February 2006.
9. World Health Organization Collaborating Centre for Drug Statistics Methodology (2006) About the ATC/DDD system. Oslo: World Health Organization Collaborating Centre for Drugs Statistics Methodology. Available: http://www.whocc.no/atcddd/atcsystem.html. Accessed 12 April 2006.
10. Aarnes EA (2003) Lønnsstatistikk for apotekansatte farmasøyter 2002. Nord Farm Tidskr 111: 26-27.
11. Schneeweiss S, Dormuth C, Grootendorst P, Soumerai SB, Maclure M (2004) Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residents. Med Care 42: 653-660.
12. ALLHAT Collaborative Research Group (2000) Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA 283: 1967-1975.
13. Verma S, Strauss M (2004) Angiotensin receptor blockers and myocardial infarction. BMJ 329: 1248-1249.
14. Tørisen HM, editor (2003) Felleskatalog over farmasøytiske spesialpreparater markedsført i Norge 2003. Oslo: Felleskatalogen. 1,723 p.